Showing results (191-200 of 282) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council reportFabiana Ostronoff, Megan Othus, Michelle Lazenby, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2013
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantationMarcos de Lima, David L Porter, Minoo Battiwalla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trialAlan S Wayne, Robert J Kreitman, Harry W Findley, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2018
5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotoxFabian Müller, Tyler Cunningham, Stephanie Stookey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2014
Feasibility of treating post-transplantation minimal residual disease in children with acute leukemiaNirali N Shah, Michael J Borowitz, Nancy C Robey, et al.
Biomarker Research|March 17, 2023
Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patientsEra L Pogosova-Agadjanyan, Xing Hua, Megan Othus, et al.
International Journal of Hematology|November 15, 2002
Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseasesGeorge E Georges, Michael Maris, Brenda M Sandmaier, et al.
Blood Advances|October 20, 2017
US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALLFarhad Ravandi, Megan Othus, Susan M O'Brien, et al.
Plos One|April 18, 2015
Cell signaling-based classifier predicts response to induction therapy in elderly patients with acute myeloid leukemiaAlessandra Cesano, Cheryl L Willman, Kenneth J Kopecky, et al.
Blood|November 25, 2010
Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up resultsHagop M Kantarjian, Francis J Giles, Kapil N Bhalla, et al.
Pageof 29